Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...

Make her holiday season with these chic picks, spanning the luxury, the useful, the personalized, and the trendy.

Is the artificial intelligence boom just getting started, or is it an overinflated balloon poised to burst? One top stock ...

Dolby Laboratories, Inc. today announced the company's financial results for the fourth quarter and fiscal year ...